William Copalu

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

David S. Boss, Hilary Glen, Jos H. Beijnen et al. · British Journal of Cancer · 2012 · 185 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +6

Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

Pratik Bhagunde, Parul Patel, Mallika Lala et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 59 citations · Full text

Population Pharmacokinetic Analysis, Pharmacotherapy, Nephrology +22

Developing a new formulation of sodium phenylbutyrate

Nathalie Guffon, Yves Kibleur, William Copalu et al. · Archives of Disease in Childhood · 2012 · 36 citations

Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia

Munjal Patel, Francesco Bellanti, Naveen M. Daryani et al. · Clinical and Translational Science · 2021 · 30 citations · Full text

CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity

Anthe S. Zandvliet, Alwin D. R. Huitema, William Copalu et al. · Clinical Cancer Research · 2007 · 28 citations